Previous 10 | Next 10 |
No Advisory Committee meeting is planned at this time No confirmatory trial required at this time Company believes it remains on track for August 18 th target PDUFA date Sesen Bio (Nasdaq: SESN ), a late-stage clinical company developing targeted ...
wildpixel/iStock via Getty Images Shares of Sesen Bio ([[SESN]] -6.0%) are up more than 200% year-to-date as the company awaits an FDA decision on its first candidate, Vicineum (oportuzumab montatox), next month. Vicineum, which has Priority Review status for non-muscle invasive bladder cance...
How to Make Money With Penny Stocks in 2021 and 7 For Your List Making money with penny stocks is all about having a strategy. And in 2021, that strategy needs to account for all the different factors affecting the stock market right now. For example, while many thought that the pandemi...
8 Penny Stocks You Should Know About in 2021 With 2021 halfway done, penny stocks continue to fly high. Although there are hundreds of penny stocks to watch , only a handful have true intrinsic value. To understand which, it is important to make a watchlist and consider all of the f...
InvestorPlace - Stock Market News, Stock Advice & Trading Tips There are a few definitions by which investors define penny stocks. Some stick to the idea that penny stocks are those that trade below $1. This was the traditional definition of a penny stock, and the one you’re mo...
Shares of Sesen Bio Inc. (NASDAQ:SESN) traded at a new 52-week high today of $4.62. Approximately 1.2 million shares have changed hands today, as compared to an average 30-day volume of 5.9 million shares. In the past 52 weeks, shares of Sesen Bio Inc. have traded between a low of $0.66 ...
3 Biotech Penny Stocks to Watch in July 2021 Biotech penny stocks have been on fire over the past year and a half. While this began during the pandemic and the resulting focus on biotech companies working on a Covid treatment, it is now much broader. In June of 2021, investors are searc...
Shares of Sesen Bio Inc. (NASDAQ:SESN) traded at a new 52-week high today of $4.28. Approximately 1.2 million shares have changed hands today, as compared to an average 30-day volume of 5.9 million shares. Sesen Bio Inc is a late-stage clinical company engaged in next-generation antibody...
At the conclusion of the 2021 Russell indexes annual reconstitution following notable healthcare stocks will join the Russell 3000 Index, effective June 28 after the U.S. market opens.Bionano Genomics (BNGO), Asensus Surgical (ASXC), Ocugen (OCGN), Senseonics Holdings (SEN...
Sesen Bio Inc. (NASDAQ:SESN) traded today at a new 52-week high of $4.36. This new high was reached on below average trading volume as 1.2 million shares traded hands, while the average 30-day volume is approximately 5.9 million shares. Sesen Bio Inc. (NASDAQ:SESN) defies analysts with a...
News, Short Squeeze, Breakout and More Instantly...
Sesen Bio Inc. Company Name:
SESN Stock Symbol:
NASDAQ Market:
Declares Special Dividend in the Aggregate of $75 Million Approximately 88% Voted in Favor of the Merger at the Special Meeting Merger on Track to Close on March 7, 2023 Sesen Bio, Inc. (Nasdaq: SESN) (“Sesen Bio” or the “Company”), today anno...
Sesen Bio Board Believes the Pending Merger with Carisma is the Most Value-Maximizing Option for Stockholders Reiterates Support from Several of Sesen Bio’s Largest Stockholders and Two Leading Independent Proxy Advisors Sesen Bio Board Unanimously Recommends All St...
Positive Recommendations Underscore that Carisma Merger Maximizes Value for Sesen Bio Stockholders Sesen Bio Board Unanimously Recommends All Stockholders to Follow ISS and Glass Lewis’s Recommendations to Vote “FOR” Value Maximizing Merger on WHITE ...